The time has come for clinical cardiovascular trials with plaque characterization as an endpoint
- PMID: 21875863
- PMCID: PMC3258448
- DOI: 10.1093/eurheartj/ehr243
The time has come for clinical cardiovascular trials with plaque characterization as an endpoint
Figures
Comment on
-
Determinants of magnetic resonance imaging detected carotid plaque components: the Rotterdam Study.Eur Heart J. 2012 Jan;33(2):221-9. doi: 10.1093/eurheartj/ehr227. Epub 2011 Aug 6. Eur Heart J. 2012. PMID: 21821844
References
-
- Fuster V, Kelly BB, Vedanthan R. Promoting global cardiovascular health: moving forward. Circulation. 2011;123:1671–1678. - PubMed
-
- Kolodgie FD, Gold HK, Burke AP, et al. Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med. 2003;349:2316–2325. - PubMed
-
- Law MR, Wald NJ, Morris JK. The performance of blood pressure and other cardiovascular risk factors as screening tests for ischaemic heart disease and stroke. J Med Screen. 2004;11:3–7. - PubMed
-
- Sanz J, Fayad ZA. Imaging of atherosclerotic cardiovascular disease. Nature. 2008;451:953–957. - PubMed
-
- Cai JM, Hatsukami TS, Ferguson MS, Small R, Polissar NL, Yuan C. Classification of human carotid atherosclerotic lesions with in vivo multicontrast magnetic resonance imaging. Circulation. 2002;106:1368–1373. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
